DUBAI, UAE – Health Gene Technologies, a life sciences company, showcased two new laboratory instruments at the WHX Labs Dubai 2026 exhibition, marking its latest effort to expand its presence in the global diagnostics market.
Held from February 10 to 13, the event served as a platform for the company to introduce its Genetic Analyzer T2400 Series and the Automated and Integrated PCR-based Nucleic Acid Testing System X4800 to an international audience of clients, partners, and industry peers.
New Sanger Platform Targets International Laboratories
A central focus of the company's booth was the Genetic Analyzer T2400 Series, a Sanger sequencing platform designed to address fluctuating laboratory throughput demands. According to the company, the T2400 is positioned to deliver core performance and reliability on par with established international systems. The introduction of the device highlights the growing capabilities of the country's life sciences instrumentation sector. For Health Gene Technologies, the T2400 represents a milestone in demonstrating the capacity of domestically developed scientific instruments to chart an independent technological course.
New Automation System Prioritizes Workflow Flexibility
Alongside the sequencing platform, the company presented the X4800, an automated and integrated system for PCR-based nucleic acid testing. The device's design philosophy pivots on the concept of "openness" in automation. As automation becomes commonplace in laboratories, the company argues that the primary challenge is no longer automation itself, but the adaptability of the system.
The X4800 is designed to accommodate diverse workflows and consumable choices, aiming to free laboratories from the need to frequently replace equipment as technologies evolve. This approach is intended to transform the automated system from a fixed-function "black box" into a platform that users can customize and adapt over time.
Industry Dialogue Focuses on Practical Applications
Throughout the four-day exhibition, representatives from Health Gene Technologies engaged in discussions with researchers and laboratory managers from the Middle East, Africa, and Europe. The conversations centered on practical industry topics, including laboratory efficiency, strategies for automation, and long-term equipment planning.
Company leadership characterized their participation in WHX Labs Dubai as a valuable opportunity for candid dialogue with peers from diverse markets. Feedback gathered during the event is expected to contribute to the ongoing development of the company's life science tools.
